291 related articles for article (PubMed ID: 31490417)
1. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy.
Kim MN; Lee JH; Chon YE; Ha Y; Hwang SG
Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):433-439. PubMed ID: 31490417
[TBL] [Abstract][Full Text] [Related]
2. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study.
Zhu YF; Tan YF; Xu X; Zheng JL; Zhang BH; Tang HR; Yang JY
Medicine (Baltimore); 2019 Dec; 98(50):e18319. PubMed ID: 31852119
[TBL] [Abstract][Full Text] [Related]
3. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
4. Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer.
Park YE; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Han S; Jeon MY; Heo JY; Song K; Kim SU
J Gastroenterol Hepatol; 2017 Jun; 32(6):1221-1229. PubMed ID: 27859587
[TBL] [Abstract][Full Text] [Related]
5. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
[TBL] [Abstract][Full Text] [Related]
6. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
Lemoine M; Shimakawa Y; Nayagam S; Khalil M; Suso P; Lloyd J; Goldin R; Njai HF; Ndow G; Taal M; Cooke G; D'Alessandro U; Vray M; Mbaye PS; Njie R; Mallet V; Thursz M
Gut; 2016 Aug; 65(8):1369-76. PubMed ID: 26109530
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
[TBL] [Abstract][Full Text] [Related]
8. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
[TBL] [Abstract][Full Text] [Related]
9. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.
Wu X; Cai B; Su Z; Li Y; Xu J; Deng R; Wang L
J Clin Lab Anal; 2018 May; 32(4):e22341. PubMed ID: 29251384
[TBL] [Abstract][Full Text] [Related]
10. Gamma-Glutamyl Transpeptidase-to-Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease.
Luo J; Du Z; Liang D; Li M; Yin Y; Chen M; Yang L
J Clin Lab Anal; 2022 Aug; 36(8):e24596. PubMed ID: 35808928
[TBL] [Abstract][Full Text] [Related]
11. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B.
Wang J; Sun X; Wei S; Chen X; Zhu H; Liantang Y; Bao R; Du Y
BMC Gastroenterol; 2024 May; 24(1):183. PubMed ID: 38783185
[TBL] [Abstract][Full Text] [Related]
13. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
Yue W; Li Y; Geng J; Wang P; Zhang L
Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
[TBL] [Abstract][Full Text] [Related]
14. Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
Wang L; Li J; Yang K; Zhang H; Wang Q; Lv X; Guan S
Medicine (Baltimore); 2020 Jun; 99(23):e20548. PubMed ID: 32502018
[TBL] [Abstract][Full Text] [Related]
15. The gamma-glutamyl transferase to platelet ratio for noninvasive evaluation of liver fibrosis in patients with primary biliary cholangitis.
Avcioğlu U; Eruzun H; Ustaoğlu M
Medicine (Baltimore); 2022 Oct; 101(40):e30626. PubMed ID: 36221370
[TBL] [Abstract][Full Text] [Related]
16. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients.
Li X; Xu H; Gao P
Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693
[TBL] [Abstract][Full Text] [Related]
17. The gamma-glutamyl transpeptidase-to-albumin ratio predicts significant fibrosis and cirrhosis in chronic hepatitis B patients.
Li Q; Lu C; Li W; Huang Y; Chen L
J Viral Hepat; 2017 Dec; 24(12):1143-1150. PubMed ID: 28685907
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Prognostic Value of Aspartate Transaminase-to-platelet Ratio Index, Gamma-glutamyl Transpeptidase-to-platelet Ratio, and Fibrosis-4 for Compensated Hepatitis B-related Liver Cirrhosis.
Tao J; Li W; Ma X; Kong S; An Q; Wang X
J Coll Physicians Surg Pak; 2023 Aug; 33(8):941-943. PubMed ID: 37553938
[TBL] [Abstract][Full Text] [Related]
19. Optimized cutoffs of gamma-glutamyl transpeptidase-to-platelet ratio, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 scoring systems for exclusion of cirrhosis in patients with chronic hepatitis B.
Liu X; Li H; Wei L; Tang Q; Hu P
Hepatol Commun; 2022 Jul; 6(7):1664-1672. PubMed ID: 35312182
[TBL] [Abstract][Full Text] [Related]
20. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
